Teva Pharmaceuticals Announces Launch of Generic HIV Drug

The US Department of Health & Human Services reports that 1.1 million individuals in the United States are living with HIV. Furthermore, in 2016, 39,782 individuals were diagnosed with the virus. The good news is, thanks to antiretroviral therapy, a HIV diagnosis no longer equates to a death sentence. Now, Teva Pharmaceuticals Industries Ltd. has announced that

The coming of age of gene therapy: A review of the past and path forward

After three decades of hopes tempered by setbacks, gene therapy—the process of treating a disease by modifying a person’s DNA—is no longer the future of medicine, but is part of the present-day clinical treatment toolkit. The Jan. 12 issue of the journal Science provides an in-depth and timely review of the key developments that have

2018-01-15T08:03:32+00:00 Tags: |

New Therapeutic Strategy Exerts a Regenerating Effect in Parkinson’s Disease

Parkinson’s disease is currently the second most widespread neurogenerative pathology. It is a motor disorder caused by the loss of dopaminergic neurons in the black substance of the brain. These neurons are the nerve cells that produce dopamine, a neurotransmitter that plays a key role in the modulation of involuntary movements. The research carried out

2018-01-14T14:57:37+00:00 Tags: , |

MIT Spinout PlenOptika Develops Portable Device for Corrective Lens Prescriptions

Vision impairment is a major global issue. More than 2 billion people worldwide don’t have access to corrective lenses. Getting eyeglasses prescriptions is especially difficult in developing countries. Optometrists are generally located in urban centers and rarely see patients from rural areas, so many people suffer from uncorrected impairments. According to the World Health Organization,

2018-01-15T03:18:06+00:00 Tags: |

Infants in the U.S. 76 percent more likely to die

Researchers found that childhood mortality in the U.S. has been higher than all other peer nations since the 1980s; over the 50-year study period, the U.S.'s "lagging improvement" has amounted to more than 600,000 excess deaths. A report of the findings, published Jan. 8 in Health Affairs, highlights when and why the U.S.'s performance started

2018-01-10T09:44:15+00:00 Tags: |

Diabetes drug ‘significantly reverses memory loss’ in mice with Alzheimer’s

A drug developed for diabetes could be used to treat Alzheimer’s after scientists found it “significantly reversed memory loss” in mice through a triple method of action. The research, published in Brain Research, could bring substantial improvements in the treatment of Alzheimer's disease through the use of a drug originally created to treat type 2

2018-01-08T07:26:55+00:00 Tags: |

Large Portion of Oral Cancer Drugs Abandoned at Pharmacy

Oral oncoloytics have the potential to transform the cancer landscape. Instead of taking hours to travel to a hospital or an infusion center to receive cancer treatment, patients are able to take an oral drug wherever they may be. These oral cancer treatments not only allow patients to keep their schedule similar to what it

2018-01-05T10:26:20+00:00 Tags: |

FDA Commissioner on new steps to facilitate efficient generic drug review

The FDA today announced additional steps to encourage generic competition as part of our continued implementation of the Drug Competition Action Plan. This plan has three main components: reducing gaming by branded companies that can delay generic drug entry; resolving scientific and regulatory obstacles that can make it difficult to win approval of generic versions

2018-01-05T10:09:55+00:00 Tags: |

Do generic drugs compromise on quality?

You've no doubt seen them in the grocery store — typically drab-looking packages on the bottom shelf containing lower-priced generic versions of popular brand-name products. Some shoppers look at them with skepticism: Are they really as good? Or does cheaper just mean lower quality? Many people have the same questions about generic prescription medications, says

2018-01-02T08:39:22+00:00 Tags: |

The sixth taste? Calcium

Calcium is something of a double-edged sword. Too much of the essential element is as dangerous as too little, either case adversely affecting health in animals from humans to mice to fruit flies. Sensing calcium at all can be crucial. Though it doesn’t fit into the five established tastes the tongue’s receptors can identify —

2018-01-04T07:06:54+00:00 Tags: |

Ruling Against Novartis Could Have Wider Implications for Generic Drug Labels

California's Supreme Court on Thursday ruled against Novartis in a decision that could have wider implications for whether brand-name or generic drugmakers should be held liable for warning consumers of risks in their drug labels. In a departure from other recent rulings, the highest California court found that a brand-name drug manufacturer's duty to warn

2018-01-02T08:32:34+00:00 Tags: |

Decreasing Market Competition Driving Up Generic Drug Costs

As the number of manufacturers producing a generic drug increases, the costs of these drugs fall, a recent study suggests. Chintan V. Dave, PharmD, PhD, from Brigham and Women's Hospital, Boston, Massachusetts, and colleagues reported their findings in a correspondence to the editor published online December 27 in the New England Journal of Medicine. "With

2018-01-02T08:27:19+00:00 Tags: |

Can Fighting Poverty Make You Happy?

This article originally appeared on Greater Good, the online magazine of the Greater Good Science Center at UC Berkeley which kindly granted permission for use. By Jill Suttie Some years ago, filmmaker Daniel Karslake, director of the acclaimed documentary, For The Bible Tells Me So, learned that every three seconds someone around the world—usually a

2018-01-03T16:10:27+00:00 Tags: , |